Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: real lifepractice results

Basit Öğe Kaydı
dc.contributor.authorEsin, E.
dc.contributor.authorOksuzoglu, O. B. Cakmak
dc.contributor.authorBilici, A.
dc.contributor.authorCicin, I.
dc.contributor.authorYumuk, PF
dc.date.accessioned2019-07-18T13:03:17Z
dc.date.available2019-07-18T13:03:17Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.identifier.citationEsin, E. Oksuzoglu, OBC. Bilici, A . Cicin, I. Yumuk, PF. (2018). Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: real lifepractice results. Cilt:29. 104-105 ss.en_US
dc.identifier.endpage105en_US
dc.identifier.issue0en_US
dc.identifier.startpage104en_US
dc.identifier.urihttps://hdl.handle.net/11616/12755
dc.identifier.volume29en_US
dc.language.isoenen_US
dc.publisherOxford unıv press, great clarendon st, oxford ox2 6dp, englanden_US
dc.relation.ispartofAnnals of oncologyen_US
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_US
dc.titlePertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: real lifepractice resultsen_US
dc.typeArticleen_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Tıp Fakültesi, Radyasyon Onkolojisi Anabilim Koleksiyonu